News Image

Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors

Provided By GlobeNewswire

Last update: Aug 22, 2025

SAN DIEGO, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, M.D., to its Board of Directors (the “Board”) effective August 18, 2025.

Read more at globenewswire.com

GYRE THERAPEUTICS INC

NASDAQ:GYRE (9/5/2025, 3:54:55 PM)

7.66

+0.08 (+1.06%)



Find more stocks in the Stock Screener

Follow ChartMill for more